AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase

Nada Alaa El-Deen; Mai Jaballah; Abouzid, Khaled; Dokla, Eman; Serya, Rabah;

Other data

Title AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase
Authors Nada Alaa El-Deen; Mai Jaballah; Abouzid, Khaled ; Dokla, Eman ; Serya, Rabah 
Issue Date 2023
Publisher National Information and Documentation Centre (NIDOC), Academy of Scientific~…
Journal Egyptian Journal of Chemistry 
Volume 0
Issue 0
Start page 0
End page 0
ISSN 2357-0245
DOI 10.21608/ejchem.2023.231603.8488

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.